OMEGA-HYDROXY-PYRIDINE-N-OXIDE EVATANEPAG
UNII CYE6Q281VQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Omega-hydroxy-pyridine-n-oxide Evatanepag, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CYE6Q281VQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1082030-37-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

CYE6Q281VQ

CAS Registry Number

1082030-37-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OMEGA-HYDROXY-PYRIDINE-N-OXIDE EVATANEPAG

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H28N2O7S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BAPHKTXPAIARSW-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

154584984

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[n+]1(cc(ccc1)S(N(Cc2cc(ccc2)OCC(O)=O)Cc3ccc(cc3)C(CO)(C)C)(=O)=O)[O-]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Omega-hydroxy-pyridine-n-oxide Evatanepag. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.